Psychological counselling interventions to improve perceived quality of life and counter anxiety and depression in pulmonary-arterial-hypertension patients: A clinical trial
Introduction: Pulmonary Arterial Hypertension (PAH) is a rare and progressive disease, frequently associated with a worsening of perceived quality of life as well as anxiety and depression symptomatology. Psychological counselling helps the patient understand the diagnosis and prevent the onset of p...
Saved in:
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Edizioni FS
2020-12-01
|
Series: | Journal of Health and Social Sciences |
Subjects: | |
Online Access: | https://journalhss.com/wp-content/uploads/jhss_533-542-1.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832595513897123840 |
---|---|
author | Emilia TARANTINO Pietro CRESCENZO Maria CAMPOBASSO Francesca D’ALESSANDRO Paola ARGIENTO Emanuele ROMEO Stefano GHIO Patrizio VITULO Francesco PARISI Massimiliano MULÈ Carlo ALBERA Carmine Dario VIZZA Michele D’ALTO |
author_facet | Emilia TARANTINO Pietro CRESCENZO Maria CAMPOBASSO Francesca D’ALESSANDRO Paola ARGIENTO Emanuele ROMEO Stefano GHIO Patrizio VITULO Francesco PARISI Massimiliano MULÈ Carlo ALBERA Carmine Dario VIZZA Michele D’ALTO |
author_sort | Emilia TARANTINO |
collection | DOAJ |
description | Introduction: Pulmonary Arterial Hypertension (PAH) is a rare and progressive disease, frequently associated with a worsening of perceived quality of life as well as anxiety and depression symptomatology. Psychological counselling helps the patient understand the diagnosis and prevent the onset of psychopathologies. This study evaluates the effect of counselling sessions on anxiety and depression as well as the impact on self-reported quality of life in patients with PAH. Methods: Patients with a diagnosis of PAH were recruited at the Monaldi Hospital (Naples). An EQ-5D 3L que- stionnaire was administered to all patients at baseline (pre-session), three months (post-session) after the last session to patients who received psychological counselling (experimental group, EG) and after the first questionnaire to patients who did not (control group, CG). The EQ-5D index and EQ-VAS score were analysed in both groups.
Results: A sample of 50 patients with a PAH diagnosis was evaluated; among them 6% had mild PAH, 66% moderate PAH, and 28% severe PAH. The majority (53%) did not receive psychological counselling. All patients showed no significant difference in EQ-5D index (P > 0.05), EQ-VAS score (P > 0.05), and the anxiety/depression dimension (P >.05) at baseline. However, between pre- and post-session evaluations, the analysis showed a significant change in the EQ-VAS score (P = 0.00) and the anxiety/depression dimension (P = 0.02) in the EG. In the CG, there was a similar change in the anxiety/depression dimension (P = 0.00) but not in the EQ-VAS score (P = 0.05) in CG. The z-test revealed significant intergroup relations, showing that the EG had a 37% increase in perceived quality of life and a 9% reduction in anxiety and depression, while a 12% reduction was observed for the CG’s perceived quality of life and a 44% increase in anxiety and depression.
Discussion and Conclusions: This study showed that patients with PAH who received psychological support impro- ved their health-related quality of life by reducing anxiety and depression symptomatology. Our findings highlight the impact of psychological support in the treatment of patients with PAH. |
format | Article |
id | doaj-art-f7ecae346ba346fba2be26bbdc8894a6 |
institution | Kabale University |
issn | 2499-5886 2499-2240 |
language | English |
publishDate | 2020-12-01 |
publisher | Edizioni FS |
record_format | Article |
series | Journal of Health and Social Sciences |
spelling | doaj-art-f7ecae346ba346fba2be26bbdc8894a62025-01-18T18:20:31ZengEdizioni FSJournal of Health and Social Sciences2499-58862499-22402020-12-015453354210.19204/2020/psyc4Psychological counselling interventions to improve perceived quality of life and counter anxiety and depression in pulmonary-arterial-hypertension patients: A clinical trialEmilia TARANTINO0Pietro CRESCENZO1Maria CAMPOBASSO2Francesca D’ALESSANDRO3Paola ARGIENTO4Emanuele ROMEO5Stefano GHIO6Patrizio VITULO7Francesco PARISI8Massimiliano MULÈ9Carlo ALBERA10Carmine Dario VIZZA11Michele D’ALTO12Ps.D., Psychologist, Dipartimento di Cardiologia, Ospedale Monaldi – Università degli Studi “L. Vanvitelli”, NapoliPs.D., Ph.D., Psychologist, Università degli Studi di Salerno, Fisciano, Salerno, ItaliaPs.D., Psychologist, Dipartimento di Cardiologia, Ospedale Monaldi – Università degli Studi “L. Vanvitelli”, NapoliPh.D., Dipartimento di Scienze Cliniche, Interventistiche, Anestesiologiche e Cardiovascolari. Policlinico Umberto I – Università di Roma “Sapienza”, RomaM.D., Ph.D., Dipartimento di Cardiologia, Ospedale Monaldi- Università degli Studi “L. Vanvitelli”, NapoliM.D., Ph.D., Dipartimento di Cardiologia, Ospedale Monaldi- Università degli Studi “L. Vanvitelli”, NapoliM.D., Divisione di Cardiologia – Fondazione IRCCS Policlinico S. Matteo, PaviaM.D., Pneumologia, Dipartimento per il Trattamento e lo Studio delle malattie cardiotoraciche e del trapianto cardiotoracico – IRCCS ISMETT, PalermoM.D., Ph.D., Dipart.to Medico Chirurgico di Cardiologia Pediatrica – Ospedale Pediatrico Bambino Gesù, RomaM.D., Ph.D., Centro di riferimento Regionale per le Malattie Rare del Polmone- A.O.U. “Policlinico Vittorio Emanuele”- CataniaMD, Dipartimento Cardiovascolare e Toracico. AOU Città della Salute e della scienza di Torino, TorinoM.D., Ph.D, Dipartimento di Scienze Cliniche, Interventistiche, Anestesiologiche e Cardiovascolari.Policlinico Umberto I – Università di Roma “Sapienza”, RomaM.D., Ph.D., Dipartimento di Cardiologia, Ospedale Monaldi- Università degli Studi “L. Vanvitelli”, NapoliIntroduction: Pulmonary Arterial Hypertension (PAH) is a rare and progressive disease, frequently associated with a worsening of perceived quality of life as well as anxiety and depression symptomatology. Psychological counselling helps the patient understand the diagnosis and prevent the onset of psychopathologies. This study evaluates the effect of counselling sessions on anxiety and depression as well as the impact on self-reported quality of life in patients with PAH. Methods: Patients with a diagnosis of PAH were recruited at the Monaldi Hospital (Naples). An EQ-5D 3L que- stionnaire was administered to all patients at baseline (pre-session), three months (post-session) after the last session to patients who received psychological counselling (experimental group, EG) and after the first questionnaire to patients who did not (control group, CG). The EQ-5D index and EQ-VAS score were analysed in both groups. Results: A sample of 50 patients with a PAH diagnosis was evaluated; among them 6% had mild PAH, 66% moderate PAH, and 28% severe PAH. The majority (53%) did not receive psychological counselling. All patients showed no significant difference in EQ-5D index (P > 0.05), EQ-VAS score (P > 0.05), and the anxiety/depression dimension (P >.05) at baseline. However, between pre- and post-session evaluations, the analysis showed a significant change in the EQ-VAS score (P = 0.00) and the anxiety/depression dimension (P = 0.02) in the EG. In the CG, there was a similar change in the anxiety/depression dimension (P = 0.00) but not in the EQ-VAS score (P = 0.05) in CG. The z-test revealed significant intergroup relations, showing that the EG had a 37% increase in perceived quality of life and a 9% reduction in anxiety and depression, while a 12% reduction was observed for the CG’s perceived quality of life and a 44% increase in anxiety and depression. Discussion and Conclusions: This study showed that patients with PAH who received psychological support impro- ved their health-related quality of life by reducing anxiety and depression symptomatology. Our findings highlight the impact of psychological support in the treatment of patients with PAH.https://journalhss.com/wp-content/uploads/jhss_533-542-1.pdfanxiety; counselling psychology; depression; eq-vas; eq-5d; pulmonary arterial hypertension; quality of life. |
spellingShingle | Emilia TARANTINO Pietro CRESCENZO Maria CAMPOBASSO Francesca D’ALESSANDRO Paola ARGIENTO Emanuele ROMEO Stefano GHIO Patrizio VITULO Francesco PARISI Massimiliano MULÈ Carlo ALBERA Carmine Dario VIZZA Michele D’ALTO Psychological counselling interventions to improve perceived quality of life and counter anxiety and depression in pulmonary-arterial-hypertension patients: A clinical trial Journal of Health and Social Sciences anxiety; counselling psychology; depression; eq-vas; eq-5d; pulmonary arterial hypertension; quality of life. |
title | Psychological counselling interventions to improve perceived quality of life and counter anxiety and depression in pulmonary-arterial-hypertension patients: A clinical trial |
title_full | Psychological counselling interventions to improve perceived quality of life and counter anxiety and depression in pulmonary-arterial-hypertension patients: A clinical trial |
title_fullStr | Psychological counselling interventions to improve perceived quality of life and counter anxiety and depression in pulmonary-arterial-hypertension patients: A clinical trial |
title_full_unstemmed | Psychological counselling interventions to improve perceived quality of life and counter anxiety and depression in pulmonary-arterial-hypertension patients: A clinical trial |
title_short | Psychological counselling interventions to improve perceived quality of life and counter anxiety and depression in pulmonary-arterial-hypertension patients: A clinical trial |
title_sort | psychological counselling interventions to improve perceived quality of life and counter anxiety and depression in pulmonary arterial hypertension patients a clinical trial |
topic | anxiety; counselling psychology; depression; eq-vas; eq-5d; pulmonary arterial hypertension; quality of life. |
url | https://journalhss.com/wp-content/uploads/jhss_533-542-1.pdf |
work_keys_str_mv | AT emiliatarantino psychologicalcounsellinginterventionstoimproveperceivedqualityoflifeandcounteranxietyanddepressioninpulmonaryarterialhypertensionpatientsaclinicaltrial AT pietrocrescenzo psychologicalcounsellinginterventionstoimproveperceivedqualityoflifeandcounteranxietyanddepressioninpulmonaryarterialhypertensionpatientsaclinicaltrial AT mariacampobasso psychologicalcounsellinginterventionstoimproveperceivedqualityoflifeandcounteranxietyanddepressioninpulmonaryarterialhypertensionpatientsaclinicaltrial AT francescadalessandro psychologicalcounsellinginterventionstoimproveperceivedqualityoflifeandcounteranxietyanddepressioninpulmonaryarterialhypertensionpatientsaclinicaltrial AT paolaargiento psychologicalcounsellinginterventionstoimproveperceivedqualityoflifeandcounteranxietyanddepressioninpulmonaryarterialhypertensionpatientsaclinicaltrial AT emanueleromeo psychologicalcounsellinginterventionstoimproveperceivedqualityoflifeandcounteranxietyanddepressioninpulmonaryarterialhypertensionpatientsaclinicaltrial AT stefanoghio psychologicalcounsellinginterventionstoimproveperceivedqualityoflifeandcounteranxietyanddepressioninpulmonaryarterialhypertensionpatientsaclinicaltrial AT patriziovitulo psychologicalcounsellinginterventionstoimproveperceivedqualityoflifeandcounteranxietyanddepressioninpulmonaryarterialhypertensionpatientsaclinicaltrial AT francescoparisi psychologicalcounsellinginterventionstoimproveperceivedqualityoflifeandcounteranxietyanddepressioninpulmonaryarterialhypertensionpatientsaclinicaltrial AT massimilianomule psychologicalcounsellinginterventionstoimproveperceivedqualityoflifeandcounteranxietyanddepressioninpulmonaryarterialhypertensionpatientsaclinicaltrial AT carloalbera psychologicalcounsellinginterventionstoimproveperceivedqualityoflifeandcounteranxietyanddepressioninpulmonaryarterialhypertensionpatientsaclinicaltrial AT carminedariovizza psychologicalcounsellinginterventionstoimproveperceivedqualityoflifeandcounteranxietyanddepressioninpulmonaryarterialhypertensionpatientsaclinicaltrial AT micheledalto psychologicalcounsellinginterventionstoimproveperceivedqualityoflifeandcounteranxietyanddepressioninpulmonaryarterialhypertensionpatientsaclinicaltrial |